Publicaciones en las que colabora con Luis Martínez Martínez (26)

2024

  1. Epidemiological and clinical characterization of community, healthcare-associated and nosocomial colonization and infection due to carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in Spain

    Infection

2023

  1. Pseudomonas aeruginosa antibiotic susceptibility profiles, genomic epidemiology and resistance mechanisms: a nation-wide five-year time lapse analysis

    The Lancet Regional Health - Europe, Vol. 34

  2. Spanish Antibiogram Committee (COESANT) recommendations for cumulative antibiogram reports

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 41, Núm. 7, pp. 430-435

2021

  1. Evaluation of Vitek-MS™ and Microflex LT™ commercial systems for identification of Acinetobacter calcoaceticus–baumannii complex

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 39, Núm. 1, pp. 9-13

  2. Predicting Pseudomonas aeruginosa susceptibility phenotypes from whole genome sequence resistome analysis

    Clinical Microbiology and Infection, Vol. 27, Núm. 11, pp. 1631-1637

  3. Propensity score and desirability of outcome ranking analysis of ertapenem for treatment of nonsevere bacteremic urinary tract infections due to extended-spectrum-beta-lactamase-producing enterobacterales in kidney transplant recipients

    Antimicrobial Agents and Chemotherapy, Vol. 65, Núm. 11

2020

  1. From CLSI to EUCAST, a necessary step in Spanish laboratories

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 38, Núm. 2, pp. 79-83

  2. Recommendations of the Spanish Antibiogram Committee (COESANT) for selecting antimicrobial agents and concentrations for in vitro susceptibility studies using automated systems

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 38, Núm. 4, pp. 182-187

2018

  1. Erratum for del Barrio-Tofiño et al., "Genomics and Susceptibility Profiles of Extensively Drug-Resistant Pseudomonas aeruginosa Isolates from Spain"

    Antimicrobial agents and chemotherapy

  2. Phenotypic detection of clinical isolates of Haemophilus influenzae with altered penicillin-binding protein 3

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 37, Núm. 8, pp. 1475-1480

2017

  1. Evaluation of the carbapenem inactivation method (CIM) for detecting carbapenemase activity in enterobacteria

    Diagnostic Microbiology and Infectious Disease, Vol. 88, Núm. 3, pp. 214-218

  2. Genomics and susceptibility profiles of extensively drug-resistant pseudomonas aeruginosa isolates from Spain

    Antimicrobial Agents and Chemotherapy, Vol. 61, Núm. 11

  3. Non-molecular detection of carbapenemases in Enterobacteriaceae clinical isolates

    Journal of Infection and Chemotherapy, Vol. 23, Núm. 1, pp. 1-11

  4. Pneumococcal meningitis in Cantabria (Spain) in the pneumococcal conjugate vaccine era (2001-2015)

    Archivos Argentinos de Pediatria, Vol. 115, Núm. 2, pp. 160-164

2016

  1. Biomarker tools to design clinical vaccines determined from a study of annual listeriosis incidence in northern Spain

    Frontiers in Immunology, Vol. 7, Núm. NOV

  2. Comprehensive clinical and epidemiological assessment of colonisation and infection due to carbapenemase-producing Enterobacteriaceae in Spain

    Journal of Infection, Vol. 72, Núm. 2, pp. 152-160

  3. Correlation between MALDI-TOF Vitek-MSTM system and conventional identification methods of gastrointestinal infection causing bacteria

    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, Vol. 29, Núm. 5, pp. 265-268

  4. Informes acumulados de sensibilidad a los antimicrobianos

    Enfermedades Infecciosas y Microbiologia Clinica

2015

  1. Biofilm formation and quorum-sensing-molecule production by clinical isolates of Serratia liquefaciens

    Applied and Environmental Microbiology, Vol. 81, Núm. 10, pp. 3306-3315

2014

  1. Puntos de corte de ceftarolina

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 32, Núm. SUPPL. 2, pp. 21-26